News & Clinical Trials: Coronary

Nov 11th, 2021
Clinical Interest Article

MASTER-DAPT—coverage of TCT 2021

A randomized trial of abbreviated antiplatelet therapy outcomes in high bleeding risk patients with high thrombotic and ischemic risk.